07:00 , Sep 17, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2a (PREX2A; DEPDC2A) Studies in cell culture suggest that inhibiting PREX2A signaling could help treat cancer. In human breast...